Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
15.5M
-
Shares change
-
+155K
-
Total reported value, excl. options
-
$397M
-
Value change
-
+$4.35M
-
Number of buys
-
39
-
Number of sells
-
-14
-
Price
-
$25.61
Significant Holders of Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) as of Q3 2016
63 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q3 2016.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.5M shares
of 108M outstanding shares and own 14.31% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (4.19M shares), FMR LLC (2.66M shares), FRANKLIN RESOURCES INC (1.57M shares), RA CAPITAL MANAGEMENT, LLC (1.55M shares), Rock Springs Capital Management LP (1.02M shares), Cormorant Asset Management, LLC (901K shares), FIL Ltd (626K shares), PERCEPTIVE ADVISORS LLC (430K shares), VANGUARD GROUP INC (425K shares), and BlackRock Fund Advisors (267K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.